Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Darshana Jani

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Bioanalysis|February 21, 2015
Feasibility of immuno-PCR technology platforms as an ultrasensitive tool for the detection of anti-drug antibodiesDarshana Jani, Edward Savino, Jaya Goyal
Journal of Clinical Pharmacology|August 23, 2020
Population Pharmacokinetic Analysis of Dalteparin in Pediatric Patients With Venous ThromboembolismBharat Damle, Frank Jen, Nancy Sherman, et al.
The AAPS Journal|August 23, 2023
Evolution of Antidrug Antibody Assays During the Development of Anti-Tissue Factor Pathway Inhibitor Monoclonal Antibody MarstacimabJean Donley, Darshana Jani, Tong Zhu, et al.
The AAPS Journal|January 17, 2025
Comparison of RT-qPCR With Branched DNA to Quantify a Lipid Nanoparticle-Encapsulated mRNA Therapeutic in Serum and Liver Tissue Samples From Nonclinical PK StudiesJessica Ortiz, Laura Brunner, Lei Ci, et al.
The AAPS Journal|March 31, 2019
Neutralizing Antibody Assay Development with High Drug and Target Tolerance to Support Clinical Development of an Anti-TFPI Therapeutic Monoclonal AntibodyYuhong Xiang, Chuenlei Parng, Katrina Olson, et al.
Bioanalysis|July 31, 2015
Recommendations for the development and validation of confirmatory anti-drug antibody assaysDarshana Jani, Robin Marsden, Alvydas Mikulskis, et al.
Pediatric Blood & Cancer|June 9, 2022
A phase 2 pharmacodynamic dose-finding, safety, and efficacy study of dalteparin for pediatric venous thromboembolism treatment in children with and without cancerLisa R Hartman, Ildar Nurmeev, Pavel Svirin, et al.
The AAPS Journal|September 3, 2025
Comparison of Branched DNA to RT-qPCR Technology for the Quantitation of mRNA from mRNA-LNP Drug Product in Human SerumCarl A Luongo, Ashley D Wright, Timothy L Lochmann, et al.
The AAPS Journal|June 20, 2019
Anti-drug Antibody Assay Validation: Improved Reporting of the Assay Selectivity via Simpler Positive Control Recovery Data AnalysisBoris Gorovits, Marcela Araya Roldan, Daniel Baltrukonis, et al.
The AAPS Journal|September 18, 2015
Recommendations for Use and Fit-for-Purpose Validation of Biomarker Multiplex Ligand Binding Assays in Drug DevelopmentDarshana Jani, John Allinson, Flora Berisha, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Bioanalysis|February 21, 2015
Feasibility of immuno-PCR technology platforms as an ultrasensitive tool for the detection of anti-drug antibodiesDarshana Jani, Edward Savino, Jaya Goyal
Journal of Clinical Pharmacology|August 23, 2020
Population Pharmacokinetic Analysis of Dalteparin in Pediatric Patients With Venous ThromboembolismBharat Damle, Frank Jen, Nancy Sherman, et al.
The AAPS Journal|August 23, 2023
Evolution of Antidrug Antibody Assays During the Development of Anti-Tissue Factor Pathway Inhibitor Monoclonal Antibody MarstacimabJean Donley, Darshana Jani, Tong Zhu, et al.
The AAPS Journal|January 17, 2025
Comparison of RT-qPCR With Branched DNA to Quantify a Lipid Nanoparticle-Encapsulated mRNA Therapeutic in Serum and Liver Tissue Samples From Nonclinical PK StudiesJessica Ortiz, Laura Brunner, Lei Ci, et al.
The AAPS Journal|March 31, 2019
Neutralizing Antibody Assay Development with High Drug and Target Tolerance to Support Clinical Development of an Anti-TFPI Therapeutic Monoclonal AntibodyYuhong Xiang, Chuenlei Parng, Katrina Olson, et al.
Bioanalysis|July 31, 2015
Recommendations for the development and validation of confirmatory anti-drug antibody assaysDarshana Jani, Robin Marsden, Alvydas Mikulskis, et al.
Pediatric Blood & Cancer|June 9, 2022
A phase 2 pharmacodynamic dose-finding, safety, and efficacy study of dalteparin for pediatric venous thromboembolism treatment in children with and without cancerLisa R Hartman, Ildar Nurmeev, Pavel Svirin, et al.
The AAPS Journal|September 3, 2025
Comparison of Branched DNA to RT-qPCR Technology for the Quantitation of mRNA from mRNA-LNP Drug Product in Human SerumCarl A Luongo, Ashley D Wright, Timothy L Lochmann, et al.
The AAPS Journal|June 20, 2019
Anti-drug Antibody Assay Validation: Improved Reporting of the Assay Selectivity via Simpler Positive Control Recovery Data AnalysisBoris Gorovits, Marcela Araya Roldan, Daniel Baltrukonis, et al.
The AAPS Journal|September 18, 2015
Recommendations for Use and Fit-for-Purpose Validation of Biomarker Multiplex Ligand Binding Assays in Drug DevelopmentDarshana Jani, John Allinson, Flora Berisha, et al.
Pageof 2